![Yaron Naos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 552 042 $ al 31/07/2026
Yaron Naos is currently Chief Operating Officer at Protalix Biotherapeutics, Inc. since 2026.
Formerly, Mr. Naos was Manager-Product Research & Development at Dexxon Pharmaceuticals Ltd. Education includes an undergraduate degree from Technion-Israel Institute of Technology and an MBA from the University of Haifa.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/04/2026 | 232.929 ( 0,29 % ) | 552 042 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Director de Operaciones | 29/05/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Dexxon Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Technion-Israel Institute of Technology
 Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
 Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Dexxon Pharmaceuticals Ltd. | |
University of Haifa
 University of Haifa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
